Arena Pharma raises $33M

Arena Pharmaceuticals ($ARNA) is raising $33 million in a stock sale. Deerfield Management, a healthcare investment organization, is buying the shares for $1.65 each. Arena recently submitted new information to the FDA for its obesity drug lorcaserin, hoping to become the first drug developer to win an approval for a weight drug in more than a decade. Arena release

Suggested Articles

Biogen will develop a gene therapy with the goal of preserving and possibly restoring vision in patients with PRPF31-mutated retinitis pigmentosa.

A month after moving its COVID-19 antibody cocktail into human trials, Regeneron is testing the drug's ability to ward off COVID-19 infection.

Short reports are nothing new, but the aggressive “I’m coming after you” PR from Applied Therapeutics certainly is.